Muscarinic Antagonist Tiotropium Bromide Hydrate CAS 139404-48-1

Basic Info

Model No.: 139404-48-1

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Product Description

Tiotropium bromide hydrate cas number 139404-48-1, a specific selective anticholinergic drug for the maintenance of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, accompanied by maintenance of dyspnea Treatment and prevention of acute attack. It has a muscarinic receptor subtype MI ~ M5 similar affinity, which by inhibiting the smooth muscle M3 receptor, resulting in bronchiectasis. In the preclinical in vitro and in vivo studies, this product is dose-dependent and resistant to methacholine-induced bronchoconstriction for up to 24 hours. Most of the bronchial dilatation effects after inhalation are site-specific effects. Clinical studies have shown that the first administration in 30min can make a significant improvement in lung function, pharmacodynamics steady state within 1 week. Tiotropium monohydrate cas number 139404-48-1, significantly improves early and late peak expiratory flow (PEFR).  It has been to maintain its bronchiectasis in the one year of delivery period, and no tolerance occurred. In addition, it can significantly improve breathing difficulties

Thera. Category: Muscarinic Antagonist 

Cas No.: 139404-48-1

Synonym:tiotropium bromide hydrate;TIOTROPIUM BROMIDE MONOHYDRATE;TIOTROPIUM BROMDIE;Tiotropium;(1a,2b,4b,5a,7b)-7-[(hydroxydi-2-thienylacety l)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide hydrate

Molecular Formula:C19H22BrNO4S2.H2O

Molecular Weight: 490.43

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Synthesis Pharmaceutical Intermediates